Our Concept

Our Concept

Phytotec is specialist in the marketing and sales of evidence based natural Rx and OTC drugs, as well as medical devices.

We in-license products from foreign partners on an exclusive and long-term basis for the territory of Hungary.

Anaboliset steroidit ja generiikka Viagra lisää miesten kestävyyttä, libidoa ja seksuaalista toimintaa ja parantaa dramaattisesti seksuaalista suorituskykyä ja herkkyyttä useimmille naisille. Sitä käyttävät laajalti urheilijat ja kehonrakentajat, koska se parantaa lihasten acheter steroide danabol ds 10 120 bodybuilding rakentamista, kestävyyttä ja kestävyyttä. ANABOLISTEN STEROIDIEN JA GENERICS VIAGRAn säännöllinen käyttö vaihdevuosien aikana voi auttaa unettomuutta, hypertensiota, ärtyneisyyttä ja seksuaalisen mielenkiinnon menetystä tällä hetkellä.

We promote our products by two dedicated medical sales teams visiting general practitioners and specialists.

Prescription free products are advertised by direct consumer advertising campaigns, developed by our DTC marketing & media team.

Because of the „multinational” past of our management and marketing team, our partners can expect a professional marketing approach and appreciate a smooth business relationship.

1999

PHYTOTEC WAS FOUNDED

Phytotec was founded in 1999 by Norbert Langen, at this time country manager of Bayer Pharma in Hungary. His idea was to bring modern evidence based herbal drugs from Germany and Switzerland to Hungary.

 

First product was launched
2001

FIRST PRODUCT LAUNCHED

The first products were launched in 2001 in women’s health, promoted by a medical sales team visiting gynecologist – a concept new to the market

Over the years more herbal products followed produced by our German and Swiss partners (Schaper & Brümmer, Zeller AG) reaching market leading positions within a short time.

sedacur forte
First product was launched

2004

LAUNCH OF SEDACUR FORTE

Sedacur forte was launched in 2004. Today Sedacur leads the market of herbal sleeping and calming products.
 

Sedacur forte
Z
2008

START OF MEDICAL DEVICE BUSINESS

In 2008 Phytotec complemented its herbal drug portfolio with evidence based natural medical devices produced by Farma-Derma (Italy). Till today six medical devices were successfully launched in the areas of gynecology, urology and upper respiratory infections.

Start of medical device business
START OF MEDICAL DEVICE BUSINESS

2012

COOPERATION WITH VIFOR PHARMA

At the beginning of 2012 Phytotec signed a cooperation with Vifor Pharma the world leader in iron deficiency therapies. With Maltofer Phytotec entered the market of reimbursed RX products. Within a short time the product took over the market leader position in the oral iron replacement therapy. Other Rx products of Vifor followed.

In autumn of 2012 Phytotec started the promotion of Uro-Vaxom and Broncho-Vaxom licenced-in from OM Pharma, specialist in bacterial immunstimulating Rx drugs.

Vifor pharma
Vifor pharma
l
2013

COOPERATION WITH BITOP AG

Since 2013 Phytotec cooperates with the German based bitop AG, bringing their innovative active ingredient Ectoin to the Hungarian market

Endoral és reventil
Endoral és reventil
P

2017

FERINJECT – THE NEXT MILESTONE IN PHYTOTEC’S HISTORY

In 2017 Vifor and Phytotec expanded their successful cooperation to Ferinject, the world market leader in the iv. iron segment.

Ferinject
Ferinject
l
2018

OTC SWITCH OF MALTOFER CHEW

At the end of 2018 Phytotec succesfully switched the regulatory status of Maltofer chew OTC being the first major EU market with OTC status.

maltofer
maltofer
P

2019

OPERATIV MANAGEMENT REORGANISED

In January 2019 the operative management of the direct to consumer communication (DTC) and the medical communication was split into two dedicated business units, due the increasing complexity and different promotional needs.

Corporate
Corporate
l
2021

COOPERATION WITH URIACH GROUP

In August 2021 launch of the innovative
Colpofix gelspray for the treatment
and prevention of vaginal lesions caused by HPV.

Colpofix vaginális gélpsray HPV kezelésére és megelőzésére
Colpofix vaginális gélpsray HPV kezelésére és megelőzésére
P

2021

OTC SWITCH OF MALTOFER FOL

We proudly announce that at the end of 2021, Maltofer Fol was succesfully switched to OTC from Rx. With this step the Hungarian pharmaceutical markets leading Iron family brand become stronger.

MAltofer fol
MAltofer fol

1999

PHYTOTEC WAS FOUNDED

Phytotec was founded in 1999 by Norbert Langen, at this time country manager of Bayer Pharma in Hungary. His idea was to bring modern evidence based herbal drugs from Germany and Switzerland to Hungary.

 

2001

FIRST PRODUCT LAUNCHED

The first products were launched in 2001 in women’s health, promoted by a medical sales team visiting gynecologist – a concept new to the market

Over the years more herbal products followed produced by our German and Swiss partners (Schaper & Brümmer, Zeller AG) reaching market leading positions within a short time.

First product was launched

2004

LAUNCH OF SEDACUR FORTE

Sedacur forte was launched in 2004. Today Sedacur leads the market of herbal sleeping and calming products. 

Sedacur forte
Z

2008

START OF MEDICAL DEVICE BUSINESS

In 2008 Phytotec complemented its herbal drug portfolio with evidence based natural medical devices produced by Farma-Derma (Italy). Till today six medical devices were successfully launched in the areas of gynecology, urology and upper respiratory infections.

Start of medical device business

2012

COOPERATION WITH VIFOR PHARMA

At the beginning of 2012 Phytotec signed a cooperation with Vifor Pharma the world leader in iron deficiency therapies. With Maltofer Phytotec entered the market of reimbursed RX products. Within a short time the product took over the market leader position in the oral iron replacement therapy. Other Rx products of Vifor followed.

In autumn of 2012 Phytotec started the promotion of Uro-Vaxom and Broncho-Vaxom licenced-in from OM Pharma, specialist in bacterial immunstimulating Rx drugs.

Vifor pharma
l

2013

COOPERATION WITH BITOP AG

Since 2013 Phytotec cooperates with the German based bitop AG, bringing their innovative active ingredient Ectoin to the Hungarian market.

Endoral és reventil
P

2017

FERINJECT – THE NEXT MILESTONE IN PHYTOTEC’S HISTORY

In 2017 Vifor and Phytotec expanded their successful cooperation to Ferinject, the world market leader in the iv. iron segment.

Ferinject
l

2018

OTC SWITCH OF MALTOFER CHEW

At the end of 2018 Phytotec succesfully switched the regulatory status of Maltofer chew OTC being the first major EU market with OTC status.

maltofer
P

2019

OPERATIV MANAGEMENT REORGANISED

In January 2019 the operative management of the direct to consumer communication (DTC) and the medical communication was split into two dedicated business units, due the increasing complexity and different promotional needs.

Corporate
l

2021

COOPERATION WITH URIACH GROUP

In August 2021 launch of the innovative
Colpofix gelspray for the treatment
and prevention of vaginal lesions caused by HPV.

Colpofix vaginális gélpsray HPV kezelésére és megelőzésére
P

2021

OTC SWITCH OF MALTOFER FOL

We proudly announce that at the end of 2021, Maltofer Fol was succesfully switched to OTC from Rx. With this step the Hungarian pharmaceutical markets leading Iron family brand become stronger.

MAltofer fol

AN ORGANIZATION OF 45 MOTIVATED AND HIGHLY SKILLED EMPLOYEES

GUARANTEES THE GROWTH OF A PORTFOLIO OF 18 PRODUCTS

Facts & Figures

Over the last 20 years Phytotec has developed from a one man company into a well established pharmaceutical marketing & sales specialist.

The number of employees
went up from 25 in 2017 to 45 in 2022

Management

DR. JÁNOS DURST

DR. JÁNOS DURST

Head of Medical Communication

  •  Physician, MBA
  • More then 25 years experience in the marketing- and sales management in original Rx, generics and the OTC area working for Bayer, KRKA and Phytotec
  • Driving sustainable growth by managing change and implementing new strategies and tatics
  • Native Hungarian, fluent in English and German
DR. NORBERT LANGEN

DR. NORBERT LANGEN

CEO

  • Founder and co-owner of Phytotec
  • German & Hungarian citizen
  • Pharmacist, University of Bonn, Germany
  • Extensive marketing-, in-licensing, consulting and management experience coming from management roles in Bayer AG, Bayer Hungária as well as COO in analyze & realize AG
  • Beside his native German, fluent in English and Hungarian
DR. JÁNOS DURST

DR. JÁNOS DURST

Head of Medical Communication

  •  Physician, MBA
  • More then 25 years experience in the marketing- and sales management in original Rx, generics and the OTC area working for Bayer, KRKA and Phytotec
  • Driving sustainable growth by managing change and implementing new strategies and tatics
  • Native Hungarian, fluent in English and German
ZOLTÁN BEDNARIK

ZOLTÁN BEDNARIK

Head of Direct to Consumer Communication

  • Economist
  • 18 years experience in pharmaceutical marketing
  • Integrated marketing communication expert
  • Native Hungarian, fluent in German and English
ERZSÉBET FELNAGY

ERZSÉBET FELNAGY

Head of Finance and Administration

  • Economist
  • Auditor
  • Native Hungarian, fluent in German
DR. JÁNOS DURST

DR. JÁNOS DURST

Head of Medical Communication

  •  Physician, MBA
  • More then 25 years experience in the marketing- and sales management in original Rx, generics and the OTC area working for Bayer, KRKA and Phytotec
  • Driving sustainable growth by managing change and implementing new strategies and tatics
  • Native Hungarian, fluent in English and German
DR. NORBERT LANGEN

DR. NORBERT LANGEN

CEO

  • Founder and co-owner of Phytotec
  • German & Hungarian citizen
  • Pharmacist, University of Bonn, Germany
  • Extensive marketing-, in-licensing, consulting and management experience coming from management roles in Bayer AG, Bayer Hungária as well as COO in analyze & realize AG
  • Beside his native German, fluent in English and Hungarian
DR. JÁNOS DURST

DR. JÁNOS DURST

Head of Medical Communication

  •  Physician, MBA
  • More then 25 years experience in the marketing- and sales management in original Rx, generics and the OTC area working for Bayer, KRKA and Phytotec
  • Driving sustainable growth by managing change and implementing new strategies and tatics
  • Native Hungarian, fluent in English and German
ZOLTÁN BEDNARIK

ZOLTÁN BEDNARIK

Head of Direct to Consumer Communication

  • Economist
  • 18 years experience in pharmaceutical marketing
  • Integrated marketing communication expert
  • Native Hungarian, fluent in German and English
ERZSÉBET FELNAGY

ERZSÉBET FELNAGY

Head of Finance and Administration

  • Economist
  • Auditor
  • Native Hungarian, fluent in German

Therapeutical Area

Gynecology

Central nervous system